Artykuły w czasopismach na temat „HCV”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „HCV”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
CRAMP, M. E. "HBV + HCV = HCC?" Gut 45, nr 2 (1.08.1999): 168–69. http://dx.doi.org/10.1136/gut.45.2.168.
Pełny tekst źródłaMujeeb, Syed Abdul, Qamar Jamal, Rafique Khanani, Nayyer Iqbal i Shahnaz Kaher. "Prevalence of Hepatitis B Surface Antigen and HCV Antibodies in Hepatocellular Carcinoma Cases in Karachi, Pakistan". Tropical Doctor 27, nr 1 (styczeń 1997): 45–46. http://dx.doi.org/10.1177/004947559702700117.
Pełny tekst źródłaStroffolini, Tommaso, i Giacomo Stroffolini. "A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma". Cancers 15, nr 8 (20.04.2023): 2388. http://dx.doi.org/10.3390/cancers15082388.
Pełny tekst źródłaHuang, Yen-Tsung, Chin-Lan Jen, Hwai-I. Yang, Mei-Hsuan Lee, Jun Su, Sheng-Nan Lu, Uchenna H. Iloeje i Chien-Jen Chen. "Lifetime Risk and Sex Difference of Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B and C". Journal of Clinical Oncology 29, nr 27 (20.09.2011): 3643–50. http://dx.doi.org/10.1200/jco.2011.36.2335.
Pełny tekst źródłaPár, Alajos. "Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma". Orvosi Hetilap 150, nr 1 (1.01.2009): 19–26. http://dx.doi.org/10.1556/oh.2009.28529.
Pełny tekst źródłaHaberl, Elisabeth M., Thomas S. Weiss, Georg Peschel, Kilian Weigand, Nikolai Köhler, Josch K. Pauling, Jürgen J. Wenzel i in. "Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma". International Journal of Molecular Sciences 22, nr 10 (18.05.2021): 5297. http://dx.doi.org/10.3390/ijms22105297.
Pełny tekst źródłaFang, Lily, Amanda Yu i Jane A. Buxton. "Identification of Acute Vaccine-Preventable Hepatitis in Individuals with Chronic Hepatitis in British Columbia between 1991 and 2007". Canadian Journal of Infectious Diseases and Medical Microbiology 22, nr 1 (2011): 10–14. http://dx.doi.org/10.1155/2011/564290.
Pełny tekst źródłaBuxton, Jane A., i Jin Hee Kim. "Hepatitis A and Hepatitis B Vaccination Responses in Persons with Chronic Hepatitis C Infections: A Review of the Evidence and Current Recommendations". Canadian Journal of Infectious Diseases and Medical Microbiology 19, nr 2 (2008): 197–202. http://dx.doi.org/10.1155/2008/410362.
Pełny tekst źródłaShen, Yu-Chuan, Hui-Ching Hsu, Tzu-Min Lin, Yu-Sheng Chang, Li-Fang Hu, Lung-Fang Chen, Sheng-Hong Lin i in. "H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection". Journal of Clinical Oncology 40, nr 11 (10.04.2022): 1206–19. http://dx.doi.org/10.1200/jco.21.01802.
Pełny tekst źródłaAlhamadany, Alaa Younis Mahdy, i Wajdi Sabeeh Sadek. "Analysis of the Chromosomal Aberrations in Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Hepatocellular Carcinoma Patients (HCC) in Mosul City, Iraq". NTU Journal of Pure Sciences 1, nr 2 (31.05.2022): 48–53. http://dx.doi.org/10.56286/ntujps.v1i2.210.
Pełny tekst źródłaKuo, Yuan-Hung, Tzu-Hsin Huang, Jing-Houng Wang, Yen-Yang Chen, Ming-Chao Tsai, Yen-Hao Chen, Sheng-Nan Lu, Tsung-Hui Hu, Chien-Hung Chen i Chao-Hung Hung. "Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib". Cancers 14, nr 16 (17.08.2022): 3971. http://dx.doi.org/10.3390/cancers14163971.
Pełny tekst źródłaAlhamadany, Alaa Younis Mahdy, i Wajdi Sabeeh Sadek. "Evaluation of the genotoxicity in patients with HBV, HCV, and HCC using micronucleus and comet assay in Mosul City\Iraq". International journal of health sciences 6, S1 (20.03.2022): 1567–79. http://dx.doi.org/10.53730/ijhs.v6ns1.4903.
Pełny tekst źródłaMbaga, Donatien Serge, Sebastien Kenmoe, Cyprien Kengne-Ndé, Jean Thierry Ebogo-Belobo, Gadji Mahamat, Joseph Rodrigue Foe-Essomba, Marie Amougou-Atsama i in. "Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders". PLOS ONE 17, nr 1 (21.01.2022): e0262903. http://dx.doi.org/10.1371/journal.pone.0262903.
Pełny tekst źródłaAlhamadany, Alaa Younis Mahdy, i Wajdi Sabeeh Sadek. "Evaluation of the genotoxicity and genomic instability in patients with HBV, HCV and HCC using micronucleus and comet assay". NTU Journal of Pure Sciences 1, nr 2 (31.05.2022): 54–63. http://dx.doi.org/10.56286/ntujps.v1i2.214.
Pełny tekst źródłaDickson-Spillmann, Maria, Severin Haug, Ambros Uchtenhagen, Philip Bruggmann i Michael P. Schaub. "Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection". European Addiction Research 22, nr 4 (11.12.2015): 181–91. http://dx.doi.org/10.1159/000441973.
Pełny tekst źródłaNavas, Maria-Cristina, Iris Suarez, Andrea Carreño, Diego Uribe, Wilson Alfredo Rios, Fabian Cortes-Mancera, Ghyslaine Martel i in. "Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia". Hepatitis Research and Treatment 2011 (31.10.2011): 1–10. http://dx.doi.org/10.1155/2011/582945.
Pełny tekst źródłaMinuk, GY, M. Zhang, SGM Wong, J. Uhanova, CN Bernstein, B. Martin, MR Dawood, L. Vardy i A. Giulvi. "Viral Hepatitis in a Canadian First Nations Community". Canadian Journal of Gastroenterology 17, nr 10 (2003): 593–96. http://dx.doi.org/10.1155/2003/978162.
Pełny tekst źródłaLu, Meng-Chuan, Ying-Hsuen Wu, Chi-Hsiang Chung, Hsuan-Hwai Lin, Tsai-Yuan Hsieh, Peng-Jen Chen, Wu-Chien Chien i Hsuan-Wei Chen. "Association of Hepatitis B and C Virus with the Risk of Coronary Artery Disease and Cerebrovascular Disease in Patients with Hepatocellular Carcinoma". Journal of Clinical Medicine 12, nr 7 (30.03.2023): 2602. http://dx.doi.org/10.3390/jcm12072602.
Pełny tekst źródłaDuan, Jingxian, Tianhao Mu i Shifu Chen. "The mutation profiles of HBV or HCV infected hepatocellular carcinoma patients underlie the varied responses to second-line immunotherapy." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): e16629-e16629. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e16629.
Pełny tekst źródłaSchotten, Clemens, Bastian Ostertag, Jan-Peter Sowa, Paul Manka, Lars P. Bechmann, Gudrun Hilgard, Claudio Marquardt i in. "GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients". Pharmaceuticals 14, nr 8 (27.07.2021): 735. http://dx.doi.org/10.3390/ph14080735.
Pełny tekst źródłaRahman, Md Tahminur, Rosy Sultana i Sohel Reza Chowdhury. "Seropositivity and pattern of viral hepatitis in clinically suspected cases of hepatitis in Dhaka city". Bangladesh Medical Research Council Bulletin 33, nr 3 (15.09.2010): 103–6. http://dx.doi.org/10.3329/bmrcb.v33i3.1142.
Pełny tekst źródłaAlqahtani, Saleh A., i Massimo Colombo. "Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma". Cells 10, nr 11 (9.11.2021): 3091. http://dx.doi.org/10.3390/cells10113091.
Pełny tekst źródłaShao, Yu Yun, Min-Shu Hsieh, Chung-Yi Huang, Yung-Ling Chang, Chih-Hung Hsu i Ann-Lii Cheng. "Vascular endothelial growth factor expression in hepatitis C virus (HCV)-related advanced hepatocellular carcinoma (HCC) compared with hepatitis B virus (HBV)-related advanced HCC." Journal of Clinical Oncology 31, nr 15_suppl (20.05.2013): 4115. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.4115.
Pełny tekst źródłaGaly, Olivier, Isabelle Chemin, Emilie Le Roux, Stéphanie Villar, Florence Le Calvez-Kelm, Myriam Lereau, Doriane Gouas i in. "Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand". Hepatitis Research and Treatment 2011 (30.06.2011): 1–9. http://dx.doi.org/10.1155/2011/697162.
Pełny tekst źródłaAimla, Kerstin, Justyna Dominika Kowalska, Raimonda Matulionyte, Velida Mulabdic, Anna Vassilenko, Natalie Bolokadze, David Jilich i in. "Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group". Vaccines 11, nr 5 (14.05.2023): 980. http://dx.doi.org/10.3390/vaccines11050980.
Pełny tekst źródłaHester, Caitlin A., Nicole E. Rich, Amit G. Singal i Adam C. Yopp. "Comparative Analysis of Nonalcoholic Steatohepatitis– Versus Viral Hepatitis– and Alcohol-Related Liver Disease–Related Hepatocellular Carcinoma". Journal of the National Comprehensive Cancer Network 17, nr 4 (kwiecień 2019): 322–29. http://dx.doi.org/10.6004/jnccn.2018.7105.
Pełny tekst źródłaAkashi, Hayato, i Masaaki Hidaka. "Comparison of the pathological features among HBV, HCV, and nonviral etiology-related hepatocellular carcinoma using explanted whole liver examinations." Journal of Clinical Oncology 35, nr 4_suppl (1.02.2017): 245. http://dx.doi.org/10.1200/jco.2017.35.4_suppl.245.
Pełny tekst źródłaC, Nwangburuka, Ijomah M A i Nwakuya M T. "Heteroscedasticity of unknown form: a comparison of five heteroscedasticity-consistent covariance matrix (hccm) estimators". Global Journal of Pure and Applied Sciences 29, nr 1 (16.05.2023): 83–90. http://dx.doi.org/10.4314/gjpas.v29i1.10.
Pełny tekst źródłaCortes-Mancera, Fabian, Carmen Luisa Loureiro, Sergio Hoyos, Juan-Carlos Restrepo, Gonzalo Correa, Sergio Jaramillo, Helene Norder, Flor Helene Pujol i Maria-Cristina Navas. "Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia". Hepatitis Research and Treatment 2011 (20.09.2011): 1–10. http://dx.doi.org/10.1155/2011/363205.
Pełny tekst źródłaPatt, Y. Z., C. Charnsangavej, B. Yoffe, R. Smith, D. Lawrence, V. Chuang, H. Carrasco, M. Roh, J. Chase i H. Fischer. "Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival." Journal of Clinical Oncology 12, nr 6 (czerwiec 1994): 1204–11. http://dx.doi.org/10.1200/jco.1994.12.6.1204.
Pełny tekst źródłaPetruzziello, Arnolfo. "Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma". Open Virology Journal 12, nr 1 (28.02.2018): 26–32. http://dx.doi.org/10.2174/1874357901812010026.
Pełny tekst źródłaYen, Yi-Hao, Kwong-Ming Kee, Wei-Feng Li, Yueh-Wei Liu, Chih-Chi Wang, Tsung-Hui Hu, Ming-Chao Tsai, Yuan-Hung Kuo i Chih-Yun Lin. "Causes of Death among Patients with Hepatocellular Carcinoma According to Chronic Liver Disease Etiology". Cancers 15, nr 6 (9.03.2023): 1687. http://dx.doi.org/10.3390/cancers15061687.
Pełny tekst źródłaTong, C. Y. W., R. Khan, N. J. Beeching, W. U. Z. Tariq, C. A. Hart, N. Ahmad i I. A. Malik. "The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellula carcinoma". Epidemiology and Infection 117, nr 2 (październik 1996): 327–32. http://dx.doi.org/10.1017/s0950268800001503.
Pełny tekst źródłaQiu, Jinrong, Weifeng Wang, Yingmei Li i Shifu Chen. "Comparison of mutational landscape of non-alcoholic fatty liver disease, viral hepatitis, and alcohol consumption related hepatocellular carcinoma." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): e16614-e16614. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e16614.
Pełny tekst źródłaPseush, S. Yu, L. V. Zozulya i L. L. Mikhaleva. "The predictive value indicators of first trimester biochemical screening in assessing unfavorable factors of pregnancy course in women with HIV as well as hepatitis B and C". Obstetrics, Gynecology and Reproduction 15, nr 6 (12.01.2022): 686–94. http://dx.doi.org/10.17749/2313-7347/ob.gyn.rep.2021.240.
Pełny tekst źródłaHuang, Xiao-wen, Bing Liao, Yang Huang, Jin-yu Liang, Quan-yuan Shan, Shun-li Shen, Xiao-yan Xie, Ming-de Lu, Li-da Chen i Wei Wang. "Non-Invasive Diagnostic Criteria for Hepatocellular Carcinoma in Hepatitis B Virus-Endemic Areas: Is Cirrhosis Indispensable?" Digestive Diseases 36, nr 3 (2018): 228–35. http://dx.doi.org/10.1159/000486196.
Pełny tekst źródłaKishta, Sara, Ashraf Tabll, Tea Omanovic Kolaric, Robert Smolic i Martina Smolic. "Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals". Biomedicines 8, nr 6 (25.06.2020): 175. http://dx.doi.org/10.3390/biomedicines8060175.
Pełny tekst źródłaKanda, Tatsuo, Taichiro Goto, Yosuke Hirotsu, Mitsuhiko Moriyama i Masao Omata. "Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review". International Journal of Molecular Sciences 20, nr 6 (18.03.2019): 1358. http://dx.doi.org/10.3390/ijms20061358.
Pełny tekst źródłaAlhaqbani, Abdulaziz H., Abdulaziz Almusalam, Abdulaziz Alnadhari, Abdulmalik Alsalem, Meshal Alrasheed, Abduljaleel Alalwan i Bander Aldamkh. "The prevalence and associated factors of viral hepatitis and cryptogenic related hepatocellular carcinoma at King Abdulaziz Medical city-Riyadh". International Journal Of Community Medicine And Public Health 6, nr 2 (24.01.2019): 561. http://dx.doi.org/10.18203/2394-6040.ijcmph20190060.
Pełny tekst źródłaHiggs, Martin R., Philippe Chouteau i Hervé Lerat. "‘Liver let die’: oxidative DNA damage and hepatotropic viruses". Journal of General Virology 95, nr 5 (1.05.2014): 991–1004. http://dx.doi.org/10.1099/vir.0.059485-0.
Pełny tekst źródłaHsiao, Yi-Wen, Lu-Ting Chiu, Ching-Hsuan Chen, Wei-Liang Shih i Tzu-Pin Lu. "Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas". Genes 10, nr 8 (20.08.2019): 630. http://dx.doi.org/10.3390/genes10080630.
Pełny tekst źródłaGlitscher, Mirco, Eberhard Hildt i Daniela Bender. "Hepatitis B und C: Mechanismen der virusinduzierten Leberpathogenese und Tumorentstehung". Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 65, nr 2 (11.01.2022): 228–37. http://dx.doi.org/10.1007/s00103-021-03482-y.
Pełny tekst źródłaMinuk, Gerald Y., i J. Uhanova. "Viral Hepatitis in the Canadian Inuit and First Nations Populations". Canadian Journal of Gastroenterology 17, nr 12 (2003): 707–12. http://dx.doi.org/10.1155/2003/350175.
Pełny tekst źródłaSchaer, Robert, Fernanda Anjos Bastos, Juçara Magalhães Simões, Juvenal Encarnação Silva, Soraya Castro Trindade, Roberto José Meyer Nascimento, Songeli Menezes Freire i Maria Isabel Schinoni. "Seroprevalence of viral Hepatitis of enteric (A and E) and parenteral / sexual (B and C) transmission of individuals aged 30 to 70 residents in Salvador-Brazil". STUDIES IN HEALTH SCIENCES 3, nr 2 (19.05.2022): 1095–111. http://dx.doi.org/10.54022/shsv3n2-037.
Pełny tekst źródłaKee, Kwong-Ming, Chien-Hung Chen, Jui-Ting Hu, Yi-Hsiang Huang, Tsang-En Wang, Gar-Yang Chau, Kuo-Hsin Chen i in. "Secular Trends of Clinical Characteristics and Survival of Hepatocellular Carcinoma in Taiwan from 2011 to 2019". Viruses 15, nr 1 (31.12.2022): 126. http://dx.doi.org/10.3390/v15010126.
Pełny tekst źródłaRusso, Francesco Paolo, Alberto Zanetto, Elisa Pinto, Sara Battistella, Barbara Penzo, Patrizia Burra i Fabio Farinati. "Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?" International Journal of Molecular Sciences 23, nr 1 (2.01.2022): 500. http://dx.doi.org/10.3390/ijms23010500.
Pełny tekst źródłaZaki, Marco Y. W., Ahmed M. Fathi, Samara Samir, Nardeen Eldafashi, Kerolis Y. William, Maiiada Hassan Nazmy, Moustafa Fathy, Upkar S. Gill i Shishir Shetty. "Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma". Cancers 14, nr 5 (28.02.2022): 1255. http://dx.doi.org/10.3390/cancers14051255.
Pełny tekst źródłaWang, Ling, Jiabao Geng, Jie Li, Tong Li, Akira Matsumori, Yibin Chang, Fengmin Lu i Hui Zhuang. "The biomarker N-terminal pro-brain natriuretic peptide and liver diseases". Clinical & Investigative Medicine 34, nr 1 (1.02.2011): 30. http://dx.doi.org/10.25011/cim.v34i1.14910.
Pełny tekst źródłaSamson, Adel, Matthew J. Bentham, Karen Scott, Gerard Nuovo, Abigail Bloy, Elizabeth Appleton, Robert A. Adair i in. "Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer". Gut 67, nr 3 (15.11.2016): 562–73. http://dx.doi.org/10.1136/gutjnl-2016-312009.
Pełny tekst źródłaBrogden, Ruth, Su Wang i Binghong Xu. "Finding the missing millions: Integrating automated viral hepatitis screening in a hospital with care and treatment in a primary care setting." Journal of Clinical Oncology 39, nr 15_suppl (20.05.2021): 108. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.108.
Pełny tekst źródła